Patent EP4626883A1: Substituted Phenyl Dihydropyrido Pyrimidinone Derivatives

The European Patent Office has published patent application EP4626883A1 for substituted phenyl dihydropyrido pyrimidinone derivatives, filed by JANSSEN Pharmaceutica NV. This publication relates to new chemical compounds with potential pharmaceutical applications.

Quinoline Compounds as Cyclin Dependent Kinase Inhibitors

The European Patent Office has published patent application EP4514791A1, detailing substituted 6-(pyrimidin-4-yl) quinoline compounds as cyclin dependent kinase inhibitors. The application was published on March 11, 2026, and lists BeOne Medicines I GmbH as the applicant.

Substituted quinolinone compounds as cyclin dependent kinase inhibitors

The European Patent Office has published patent application EP4514797A1 concerning substituted quinolinone compounds as cyclin-dependent kinase inhibitors. The application was filed by BeOne Medicines I GmbH and lists Jing Li, Wenqing Xu, and Zhiwei Wang as inventors. This publication relates to new chemical entities for potential therapeutic use.

Patent Publication EP2023205892A1: CDK Inhibitors and Pharmaceutical Uses

The European Patent Office has published patent application EP2023205892A1 concerning CDK inhibitors and their pharmaceutical uses, filed by Risen (Suzhou) Pharma Tech Co., Ltd. This publication provides details on the chemical compounds and their potential applications in treating diseases.

Patent EP4629988A1: Indole derivatives for cancer, infections

The European Patent Office has published patent application EP4629988A1 concerning indole derivatives for the treatment of cancer and infections. The patent was published on March 11, 2026, and lists Centre National de la Recherche Scientifique, Paris Sciences et Lettres, and Institut Curie as applicants.

Amide compounds activate potassium channels for CNS/PNS disorders

The European Patent Office has published patent application EP4630406A1 concerning amide compounds that activate potassium channels, useful for treating CNS and PNS disorders. The patent application was filed by Angelini Pharma S.P.A. and lists several inventors.

EPO Patent Publication EP4626870A1 on Noncovalent KEAP1-NRF2 Inhibitors

The European Patent Office has published patent application EP4626870A1 concerning noncovalent KEAP1-NRF2 small-molecule inhibitors. The publication lists the University of Copenhagen as the applicant and details inventors and IPC classifications related to organic chemistry and pharmaceutical applications.

Microbiocidal Tetrahydroisoquinoline Derivatives Patent EP4626882A1

The European Patent Office has published patent application EP4626882A1 concerning microbiocidal tetrahydroisoquinoline derivatives. The application was filed by Syngenta Crop Protection AG and lists several inventors. The patent is designated for multiple European countries.

Azole Compound and Antifungal Agent Patent EP4495114A1

The European Patent Office has published patent application EP4495114A1 for an azole compound and antifungal agent, filed by Nihon Nohyaku Co., Ltd. The patent covers specific chemical structures and their application as antifungal agents, with designated states across Europe.

Patent EP4626874A1: Spirocyclic Kras Inhibitors Preparation

The European Patent Office has published patent application EP4626874A1 concerning processes and intermediates for the preparation of spirocyclic Kras inhibitors. The application was filed by Boehringer Ingelheim International GmbH and lists ZHANG, Yongda et al. as inventors. The publication date is March 11, 2026.